Related Experiment Video
Updated: Jul 23, 2026
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Immobilized amyloid precursor protein constructs: a tool for the in vitro screening of glial cell reactivity
R von Bernhardi1, G Ramírez, H Matile
1Faculty of Medicine, Universidad de los Andes, San Carlos de Apoquindo 2200, Las Condes, Santiago, Chile. rvonb@uandes.cl
Abstract:
Astrocytes and microglia are closely associated with amyloid plaques in Alzheimer's disease (AD). Microglia constitute the first barrier surrounding plaques, although they seem to be unable to remove them efficiently. We evaluated the reaction of microglial cells from neonatal rats and mice to plaque mimetics. The C-terminal part of the amyloid precursor protein (APP) or amyloid peptide (A beta) was immobilized to either 60-microm or 2.8-microm beads and incubated with microglial cells. Beads of 60 microm, having approximately the size of senile plaques, were not phagocytosed, in contrast to 2.8-microm beads, which were phagocytosed by microglia but not by astrocytes. Once taken up by the cells, proteins immobilized to the beads were degraded rapidly, as confirmed by mass spectrometry and immunofluorescence with an antibody against beta-amyloid. On the other hand, no protein degradation was observed with 60-microm beads. Also, probably as a reaction to its incapability to phagocytose the beads, glia organized around the beads and started to proliferate. Cell proliferation was more pronounced when the beads contained the A beta epitope compared with the beads with an inert surface. This in vitro effect could be exploited to set up a screening assay for compounds that ameliorate the adverse reaction of microglia supposed to contribute to the pathogenesis of AD.
Insights
Microglia surround amyloid plaques in Alzheimer's disease but cannot clear them. Larger plaque-mimicking beads were not ingested, causing microglia to proliferate, suggesting a target for new Alzheimer's therapies.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia and astrocytes are key glial cells in Alzheimer's disease (AD) pathogenesis, closely interacting with amyloid plaques.
- Microglia form an initial barrier around amyloid plaques but struggle with efficient clearance, potentially contributing to AD progression.
Purpose of the Study:
- To investigate the in vitro response of microglial cells to amyloid precursor protein (APP) and amyloid-beta (A beta) peptide mimics.
- To understand how microglial interaction with plaque-mimicking structures influences their behavior and potential role in AD.
Main Methods:
- Immobilizing C-terminal APP or A beta peptide onto 60-microm or 2.8-microm beads.
- Incubating these beads with primary microglial and astrocyte cultures.
- Analyzing phagocytosis, protein degradation via mass spectrometry and immunofluorescence, and cell proliferation.
Main Results:
- Microglia readily phagocytosed 2.8-microm beads but not 60-microm beads, which resemble senile plaque size.
- Proteins on phagocytosed beads were rapidly degraded, while those on non-phagocytosed beads were not.
- Microglia exhibited increased proliferation around non-phagocytosed 60-microm beads, particularly those containing A beta epitopes.
Conclusions:
- Microglial phagocytic capacity is size-dependent, with larger structures like amyloid plaques being resistant to uptake.
- The inability to phagocytose larger structures may trigger detrimental microglial proliferation, contributing to AD pathogenesis.
- These findings support the development of in vitro screening assays to identify compounds mitigating adverse microglial reactions in AD.
More Related Videos
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
06:02Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025